Objective-To determine whether collagen induced arthritis (CIA) 
Mycobacterium included in complete
Freund's adjuvant and the method of emulsification) and immunological, histopathological, and pharmacological features were examined. Results-Under optimum immunisation conditions, joint inflammation developed two to three weeks after the primary immunisation with an incidence of 100% at four to five weeks. The progression of the arthritis was mild and was associated with moderate increases in concentrations ofserum IgG against type II collagen. This CIA model was similar to the conventional model in histopathological and pharmacological features. Conclusions-Murine CIA could be successfully induced by a single immunisation. An important feature of this model was a mild progression of joint inflammation. This feature seems to be ofbenefit for monitoring the development of arthritis from an early stage in the disease and for the development of novel antirheumatic drugs for such early stage patients.
(Ann Rheum Dis 1996; 55: [535] [536] [537] [538] [539] In 1977 and 1980, experimental models of chronic inflammatory arthritis were developed in rats2 and mice.3 These collagen induced arthritis (CIA) models resembled human rheumatoid arthritis."A Arthritis in rats has been induced by a single injection of type II collagen emulsified in Freund's incomplete adjuvant. The joint inflammation develops two to three weeks after the primary sensitisation. On the other hand, arthritis in mice has usually been induced by two injections of type II collagen emulsified in Freund's complete or incomplete adjuvant. The joint inflammation develops four to five weeks after the primary sensitisation. The susceptibility of mice to arthritis and immune responses to collagen are under the control of the major histocompatibility complex.5 As traditional NSAIDs and DMARDs had no effect on joint inflammation in this mouse model, it could be applied to the discovery of novel immunosuppressive agents.6
Although there are many studies on the mouse model, no attempt has so far been made to explain why the secondary immunisation is generally required to induce arthritis in mice. Therefore, we examined whether the incidence of arthritis could be improved by modifications The mice were examined weekly throughout the test. The degree of arthritis was represented by scores from 0 to 3 points per foot, maximum of 12 points as the total score of four feet: 0 points: no change; 1 point: detectable swelling in one or more digital joints; 2 points: mild swelling in one or more joints; 3 points: severe swelling of the entire paw or ankylosis.
MEASUREMENT OF ANTIBODY CONCENTRATIONS
Serum antibody titres were measured by modification of an enzyme linked immunosorbent assay (ELISA) described previously.7 Firstly, the 96 well microplate was coated with 50 ,u/well of a 10 ,ug/ml solution of C II at room temperature for 60 minutes, and then blocked with PBS containing 0 1% BSA at room temperature for 60 minutes. Then the diluted serum (1:2500) was added at 50 ,u/well and allowed to react at room temperature for 60 minutes. Results and discussion Collagen induced arthritis can be generated by a single immunisation with C II. On the other hand, CIA in mice is generally believed to require a second immunisation. Why reimmunisation is required to induce arthritis in mice has not been reported. Our study started from our idea that autoimmune diseases could be induced by a single immunisation if it was satisfactorily performed. Pathogenetically, this represents a more natural model of autoimmune disease than when induction by reimmunisation is required.
Firstly, we examined under which conditions induction of arthritis was more efficient, focusing on two points to which little attention has been paid previously -the species of Mycobacterium included in Freund's complete adjuvant, and the method of emulsification of antigen with the adjuvant. We investigated whether there were any differences in the incidence of arthritis between mice inoculated with Freund's complete adjuvant containing M tuberculosis and those injected with the same adjuvant containing M butyricum. We also determined which method of emulsification -ultrasonication or connected syringes -was more efficient for induction of arthritis. Table 1 shows the time course of induction of arthritis by these modified immunisation procedures. The most efficient condition was immunisation with an ultrasonic emulsion of C II in Freund's complete adjuvant containing M tuberculosis. Under these conditions, the time of onset was two to three weeks and the incidence was 100% at four to five weeks. Under all other conditions examined, the incidence was less and the time of onset was prolonged. This selection of species of Mycobacterium as well as the method of emulsification of antigen with Freund's complete adjuvant seem important for successful induction of arthritis with a single immunisation.
The importance of IgG antibodies against C II in initiating arthritis has been shown.' 9 Therefore, the concentrations of serum anti-C II IgG were measured two weeks after the first immunisation, in the early stage of arthritis. Figure 1 shows that the most efficient conditions (ultrasonic emulsification and M et al showed the importance of adjuvant composition in the induction of CIA in mice.'0 Although M tuberculosis induced a potent T cell response against C II, by contrast M butyricum did not. This finding also supports the previous observation that the development of the full pattern of CIA requires synergistic activation of both humoral and cell mediated responses." Recently, Germann et al reported that interleukin-1 2 (IL-12) could replace Mycobacteria and cause severe arthritis in mice when given in combination with C II. 12 This cytokine stimulates interferon--y (IFN--y) synthesis and strongly enhances Thi cell development. '3 " Further studies on cytokines such as IL-12 and IFN--y relating to inflammation and immune responses may be necessary to elucidate the relation between incidence of CIA and the species of mycobacteria. Small mycobacterial fragments are known to be efficient at inducing adjuvant arthritis.'5 If the resistance of the cell wall to ultrasonication differs between M tuberculosis and M butyricum, it is possible that the degree of arthritis may be dependent on the mycobacterial particle size after ultrasonication. At present, we have no data on particle size. How differences in species or particle size of Mycobacteria in the adjuvant influence immunising capability is a topic for future study.
Ultrasonication can induce heating of samples. However, the temperature of the antigen should not be allowed to become excessively high. Immunisation of mice with heat denatured collagen results in the failure of induction of inflammatory arthritis," 16 and this was associated with the lack of antibodies against conformational determinants present selectively on native antigen.'6 Therefore, in this study, the ultrasonication was performed on ice. It is important to make a high quality emulsion without a temperature increase. These findings showed that the incidence of mouse arthritis could be altered by slight modifications of the immunisation conditions, and that arthritis could be reproducibly and sufficiently induced by a single immunisation under the conditions described above. The immunisation conditions used here seem to be widely applicable to other models of autoimmune diseases as well as to efficient collection of IgG antibody from the inoculated animal.
Histopathological and pharmacological features of this CIA model were examined. Histopathologically, the arthritic lesions showed synovial proliferation, infiltration with mononuclear cells and granulocytes, fibrin deposits, pannus formation with damage to the cartilage, and bone erosion (fig 2) . These features were similar to those of human rheumatoid arthritis and the conventional murine CIA.SA On the other hand, as conventional NSAIDs and DMARDs have little effect on joint inflammation in the conventional CIA model, the conventional model may be used to characterise novel immunosuppressive agents.6 Accordingly, the effects of conventional antirheumatic drugs on this CIA model were examined. As shown in Table 2 Effects of antiarthritic drugs on CIA in mice Mice were dosed with the drugs daily for four weeks, starting two weeks after immunisation. Physiological saline was given to the controls in the same manner. All four limbs of each mouse were scored for arthritis on the day after the drug was last given. Drugs were given by mouth except for dexamethasone, which was given by intraperitoneal route. C II. This phenomenon is a matter of course in secondary immune responses against a foreign antigen, but seems not to be pathogenetically natural as a model of autoimmune disease. Autoantigens which are always present in the body should be able to provide continuous stimuli to immune systems. Accordingly, the second immunisation should be theoretically unnecessary for induction of autoimmunity if the first inoculation with antigen is performed satisfactorily. The successful induction of arthritis such as in this CIA model supports this idea.
This model has some advantages over the conventional CIA model. Firstly, as arthritis can be induced by only one immunisation, it will be more economical, saving time, manpower, and cost. Secondly, joint inflammation develops two to three weeks after the primary immunisation (similarly to the rat CIA model) and the incidence is 100% at four to five weeks. This time is convenient for evaluation of drugs using a model of chronic autoimmune disease. Thirdly, the progression of arthritis is mild. This is a beneficial feature for a model of chronic disease, and may be useful for the discovery of more extensive antirheumatic agents. Also, the importance of immunotherapy in the early stage of rheumatoid arthritis has been stressed recently. 17 Thus this model will be more helpful in the discovery and development of drugs for patients in the early stages of rheumatoid arthritis.
Single injection CIA models in rats have already been established for pharmacological studies. However, these models have disadvantages in comparison with our model in mice. Firstly, the lower incidence of arthritis (400/6-50%)2 makes statistical evaluation of the effects of drugs difficult, and the development and peak (three weeks after the first immunisation) of arthritis are rapid. Recently, the single injection protocol has been developed successfully (100%) in DA rats using Freund's incomplete adjuvant. 8 The same rats, however, developed an acute arthritis after injection with Freund's incomplete adjuvant alone (oil-adjuvant induced arthritis, OAIA). The combination of CIA and OAIA in this model seems to make evaluation of the effects of drugs more complicated.
In conclusion, murine CIA was successfully induced by a single immunisation. Two major considerations regarding the immunisation protocol determine success -namely, the use of Freund's complete adjuvant containing M tuberculosis but not M butyricum as an adjuvant and production using ultrasonication of a high quality antigen emulsion in Freund's complete adjuvant without heating. This CIA model was basically similar to the conventional model in histopathological and pharmacological features. However, the progression of joint inflammation in our model was mild. These findings suggest that this model will be helpful in the discovery and development of novel antirheumatic drugs for patients in an early stage of the disease and also in studying the immune phenomena involved in the development of rheumatoid arthritis. The immunisation conditions used in this CIA model could be widely applicable to development of models of other autoimmune diseases.
